Remove Communication Remove Documentation Remove White Paper
article thumbnail

White paper reveals pathway for digital therapeutics use in Italy

pharmaphorum

A white paper has outlined a pathway that could allow Italy to realise the potential of digital therapeutics (DTx). The official journal of the Smith Kline Foundation, Tendenze Nuove, has published the paper entitled “Digital Therapeutics, an Opportunity for Italy” earlier this month.

article thumbnail

Resolving challenges with product recovery in biopharma manufacturing

Pharmaceutical Technology

To learn more about how the 3M Harvest RC Chromatographic Clarifier is revolutionising biopharma production, download this specially commissioned white paper. “This can result in reductions in costs for our customers.”

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Optimising biopharma production through process intensification

Pharmaceutical Technology

To learn more about the 3M TM Harvest RC Chromatographic Clarifier and the efficiencies achievable in biopharma manufacturing, download the specially commissioned white paper on this page. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

article thumbnail

FDA suggests ways to curb constraints with rare disease gene therapy trials

Pharmaceutical Technology

In 2020, the FDA released a guidance document for the industry with recommendations for sponsors developing gene therapies for rare diseases. This document delved into aspects related to manufacturing, preclinical, and clinical trial design for all phases of clinical development.

FDA 105
article thumbnail

Overcoming challenges with scalability in biopharma manufacturing

Pharmaceutical Technology

To learn more about the ways that the 3MTM Harvest RC Chromatographic Clarifier can increase efficiencies in the production of mAb therapies, download this specially commissioned white paper. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

article thumbnail

The Incredible Shrinking Exemption: FDA Final CDS Guidance Would Significantly Narrow the Scope of Exempt Clinical Decision Support Software Under the Cures Act

The FDA Law Blog

Javitt — On September 28, 2022, the FDA issued the long anticipated final Clinical Decision Support Software Guidance (CDS Guidance), which replaces the revised draft guidance document from 2019. Other medical information.

FDA 52
article thumbnail

Pharma 4.0™ Is Gaining Momentum and Driving Innovation

ISPE

and management communication strategy. ™” is becoming an increasingly rhetorical one, particularly in view of the growing momentum in the pharmaceutical industry and in various statements and white papers from key regulatory agencies. Is the vendors’ documentation complete in order to assess GxP risks and GxP compliance?